A drug candidate, an anti-FGFR1 humanized antibody, offers fresh approach to battling aggressive lung cancer todayheadline
Researchers have introduced a new antibody-based treatment, OM-RCA-01, that has shown impressive potential in fighting lung cancer in experimental models....
Read moreDetails